Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines
CONCLUSION: Our results do support that, when compared to hormonal contraceptive use, the mRNA vaccines do not show disproportional reporting of thromboembolic events in younger women.PMID:34264151 | DOI:10.1080/14740338.2021.1955101
Source: Expert Opinion on Drug Safety - Category: Drugs & Pharmacology Authors: Maurizio Sessa Kristian Kragholm Anders Hviid Morten Andersen Source Type: research
More News: AstraZeneca | COVID-19 | Drugs & Pharmacology | Hormones | Pandemics | Pfizer | Thrombosis | Vaccines | Women